SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies

Monoclonal antibodies (mAbs) offer a treatment option for individuals with severe COVID-19 and are especially important in high-risk individuals where vaccination is not an option. Given the importance of understanding the evolution of resistance to mAbs by SARS-CoV-2, we reviewed the available in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, MacGregor, Peacock, Thomas P., Harvey, William T., Hughes, Joseph, Wright, Derek W., Willett, Brian J., Thomson, Emma, Gupta, Ravindra K., Peacock, Sharon J., Robertson, David L., Carabelli, Alessandro M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616429/
https://www.ncbi.nlm.nih.gov/pubmed/36307535
http://dx.doi.org/10.1038/s41579-022-00809-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616429/
https://www.ncbi.nlm.nih.gov/pubmed/36307535
http://dx.doi.org/10.1038/s41579-022-00809-7

Ejemplares similares